A Two-Arm, Non-Randomized, Multicenter, Phase 2 Study of VELCADE (Bortezomib) in Combination With Rituximab, Cyclophosphamide, and Prednisone With or Without Doxorubicin Followed by Rituximab Maintenance in Patients With Relapsed Follicular Lymphoma.
Interventional
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Number of Patients With Complete Response (CR)
Disappearance of all evidence of disease assessed by computed tomography (CT) and PET (position-emission tomography) according to the revised International Working Group (IWG) Criteria.
30 weeks
No
Medical Monitor
Study Director
Millennium Pharmaceuticals, Inc.
United States: Food and Drug Administration
C05012
NCT00715208
September 2008
March 2011
Name | Location |
---|---|
Avera Cancer Institute | Sioux Falls, South Dakota 57105 |
Marshfield Clinic | Marshfield, Wisconsin 54449 |
New York Medical College | Valhalla, New York 10595 |
Western Pennsylvania Cancer Institute | Pittsburgh, Pennsylvania 15224 |
Great Plains Regional Medical Center | North Platte, Nebraska 69101-6598 |
Southern Nevada Cancer Research Foundation | Las Vegas, Nevada 89106 |
Jackson Oncology Associates, PLLC | Jackson, Mississippi 39202 |
St. Joseph Mercy Hospital | Pontiac, Michigan 48341-2985 |
Temple University | Philadelphia, Pennsylvania 19140 |
Medical Oncology, LLC | Baton Rouge, Louisiana 70808 |
Northern Utah Associates | Ogden, Utah 84403 |
Allegheny-Singer Research Institute | Pittsburgh, Pennsylvania 15212 |
Dartmouth Hitchcock Medical Center | Lebanon, New Hampshire 03756 |
Gabrail Cancer Center | Canton, Ohio 44718 |
San Juan Oncology Associates | Farmington, New Mexico 87401 |
Hope Oncology | Richardson, Texas 75080 |
Providence Saint Joseph Medical Center | Burbank, California 91505-4866 |
Kalamazoo Hematology and Oncology | Kalamazoo, Michigan 49048 |
Nebraska Hematology-Oncology, PC | Lincoln, Nebraska 68506 |
Cancer Care Center, Inc. | New Albany, Indiana 47150 |
NYU Clinical Cancer Center | New York, New York 10016 |
Alexian Brothers Hospital Network | Elk Grove Village, Illinois 60007 |
University of Tennessee Medical Center | Knoxville, Tennessee 37920 |
Northwest Georgia Oncology Centers, PC | Marietta, Georgia 30060 |
Cancer Center of Central Connecticut | Southington, Connecticut |
Siouxland Hematology Oncology Associates | Sioux City, Iowa 51101 |
Purchase Cancer Group | Paducah, Kentucky 42002 |
Landmark Medical Center | Woonsocket, Rhode Island 02895 |
Northwest Alabama Center, PC | Muscle Shoals, Alabama 35661 |
Pacific Coast Hematology Oncology Medical Group | Fountain Valley, California 92708 |
Loma Linda U Cancer Center | Loma Linda, California 92354 |
Desert Hematology Medical Group, Inc. | Rancho Mirage, California 92270 |
Ocala Cancer Institute | Ocala, Florida 34471 |
Southern Illinois Hematology Oncology | Centralia, Illinois 62801 |
Clintell, Inc. | Skokie, Illinois 60077 |
Hutchinson Clinic | Hutchinson, Kansas 67502 |
St. Louis Cancer Care, LLP | Chesterfield, Missouri 63017 |
Interlakes Foundation | Rochester, New York 14623 |
Oklahoma Oncology and Hematology, PC | Oklahoma City, Oklahoma 73112 |
Marshall University | Huntington, West Virginia 25701 |
West Virginia University Health Science Center | Morgantown, West Virginia 26505 |